An expert panel recommended FDA to approve the Pfizer-BioNTech COVID-19 vaccine for children ages five to 11

On Tuesday, an expert committee advising the Food and Drug Administration recommended that regulators authorize Pfizer-BioNTech’s COVID-19 vaccine for 5- to 11-year-olds. With the committee’s endorsement, the Pfizer-BioNTech vaccine is set to become the first shot to be authorized for younger children.

Metro doctors explain why the Pfizer vaccine for kids is safe and effective. “No steps were missed in the development of this vaccine and in the study of this vaccine”.

About 6.3 million children have had COVID-19 during the course of the pandemic, making up about 16% of all cases in the U.S., according to the American Academy of Pediatrics.

What people are saying?

Lee Beers, M.D., FAAP I’m encouraged by and honored to work alongside dedicated pediatricians at such an important moment in the pandemic for children. We are trusted sources for families and stand ready to do all we can to support them.

Lulu We should get ALL the children first. Not only the 5-11 category that will shortly have access to the vaccine. We need quick FDA approval for the below 5 years category as well. Not in 2022 as FDA plans to do it. Please fight for your younger patient as much you did for 5-11 kids.